remdesivir new england journal of medicine

Keyword	CPC	PCC	Volume	Score	Length of keyword
remdesivir new england journal of medicine	1.77	0.1	9640	45	42
remdesivir	0.59	0.6	8535	74	10
new	1.32	0.8	3955	66	3
england	2	0.7	3902	78	7
journal	0.7	0.4	1452	27	7
of	1.25	1	8017	28	2
medicine	1.24	0.6	4691	21	8

Keyword	CPC	PCC	Volume	Score
remdesivir new england journal of medicine	1.31	0.2	5397	90
new england journal of medicine on remdesivir	0.45	0.3	6968	72
new england journal medicine remdesivir	0.72	0.3	5737	100
new england journal of medicine remdesivir	0.69	0.3	2069	22

Search Results related to remdesivir new england journal of medicine on Search Engine

Remdesivir for the Treatment of Covid-19 — Final Report | NEJM
nejm.org

https://www.nejm.org/doi/full/10.1056/NEJMoa2007764

May 22, 2020 · Among the 913 patients receiving oxygen at enrollment, those in the remdesivir group continued to receive oxygen for fewer days than patients in …

DA: 43 PA: 78 MOZ Rank: 74

Early Remdesivir to Prevent Progression to Severe Covid-19 in
nejm.org

https://www.nejm.org/doi/full/10.1056/NEJMoa2116846

Dec 22, 2021 · Original Article from The New England Journal of Medicine — Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients. Original Article from The New England Journal of Medicine ...

DA: 98 PA: 67 MOZ Rank: 6

Medicines | Gilead
gilead.com

https://www.gilead.com/science-and-medicine/medicines

BACK TO MAIN MENU Company Statements Gilead Statement on U.S. Supreme Court Overturning Roe v. Wade All Magrolimab Studies Re-Opening for Patient Enrollment in the U.S. Gilead Statement on WHO Recommendation of Veklury® (Remdesivir) and Acceleration of Prequalification Submission Gilead Implements Contract Pharmacy Integrity Initiative for Branded Hepatitis C Products Gilead to …

DA: 94 PA: 27 MOZ Rank: 20

Coronavirus (COVID-19) : NEJM Journal Watch
jwatch.org

https://www.jwatch.org/covid-19

Jun 09, 2022 · NEJM Journal Watch reviews over 250 scientific and medical journals to present important clinical research findings and insightful commentary ... Optimizing Remdesivir's Use for COVID-19: Infection vs. Inflammation. George Sakoulas, ... A new guideline describes evidence and clinical considerations for the use of aducanumab to treat patients ...

DA: 22 PA: 69 MOZ Rank: 51

Final report confirms remdesivir benefits for COVID-19
nih.gov

https://www.nih.gov/news-events/nih-research-matters/final-report-confirms-remdesivir-benefits-covid-19

The final report appeared in the New England Journal of Medicine on October 8, 2020. Scientists randomly assigned 1,062 hospitalized COVID-19 patients to receive remdesivir or a placebo plus standard treatment. The patients received an intravenous …

DA: 49 PA: 98 MOZ Rank: 11

FDA Approves First COVID Treatment for Young Children Despite …
theepochtimes.com

https://www.theepochtimes.com/fda-covid-treatment-children_4496793.html

May 27, 2022 · A clinical trial published in The New England Journal of Medicine examined the efficacy of remdesivir in treating COVID-19 infections. The trial had a small number of participants; it …

DA: 44 PA: 83 MOZ Rank: 17

Eric Topol - Wikipedia
wikipedia.org

https://en.wikipedia.org/wiki/Eric_Topol

Eric Jeffrey Topol (born 26 June 1954) is an American cardiologist, scientist, and author.He is the founder and director of the Scripps Research Translational Institute, a professor of Molecular Medicine at The Scripps Research Institute, and a senior …

DA: 78 PA: 80 MOZ Rank: 66

COVID-19 Treatments: What We Know So Far - Yale Medicine
yalemedicine.org

https://www.yalemedicine.org/news/covid-19-treatment-drugs

May 19, 2022 · The antiviral treatment remdesivir, sold under the brand name Veklury, was the first COVID-19 therapy to get full FDA approval, and, so far, it's still the only one. Although originally used in COVID-19 patients only after they were hospitalized, new data suggests it can be helpful in outpatients who become infected and who are at high risk for ...

DA: 58 PA: 86 MOZ Rank: 75